Physician profile
Ann Murray
NPI 1194081968
$12,409.70
in general payments reported to CMS, 2019-2025
10 companies · $1,946 in 2025
The $1,946 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2020: $726 · 2022: $5,708 · 2023: $1,259 · 2024: $2,064 · 2025: $1,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,682 · Food and Beverage: $1,386 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,681.82 |
| Food and Beverage | $1,386.13 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insightec,INC | $8,851.28 | 2020-2025 | Exablate |
| Medtronic, INC. | $1,971.60 | 2024 | Percept Pc Brainsense |
| Medtronic USA, INC. | $1,328.72 | 2019-2020 | |
| Abbott Laboratories | $107.65 | 2022-2024 | Infinity |
| Mdd US Operations, LLC | $49.34 | 2025 | |
| Abbvie INC. | $26.88 | 2025 | |
| Boston Scientific Corporation | $22.77 | 2025 | General - Dbs |
| Acadia Pharmaceuticals INC | $21.93 | 2024 | Nuplazid |
| Biogen, INC. | $15.57 | 2020 | |
| Amneal Pharmaceuticals LLC | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.